| NCT ID | NCT03076372 |
| Title | A Study Evaluating MM-310 in Patients With Solid Tumors |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merrimack Pharmaceuticals |
| Indications |
gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer |
| Therapies | |
| Age Groups: | senior adult |